Novartis Must Face Claims Alleging Kickbacks for MS Drug Promotion, Appeals Court Rules

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.37 CHF | -2.46% |
|
-1.51% | +7.52% |
02-13 | European companies cut jobs as economy slows | RE |
02-13 | Novartis Faces 'Sharp Deceleration' in Growth in Mid-2025, UBS Says | MT |